<div class="data-content">
  <div class="mxb-6 plr-1 ptb-0-2 head-content large"><b>Bivalirudin:</b></div>
  
  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Adult starting dose:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">0.15 mg/kg/h</div>
  
  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Pediatric starting dose:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">0.3 mg/kg/h</div>
  
  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Target range:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">aPTT 60–80 s (ratio 1.5–3.0)</div>
  
  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Lower targets in VV ECMO possible:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">aPTT 45–55 s (ratio 1.35–1.65)</div>
  
  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Renal impairment dose adjustment:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">YES—adjust dose as follows:</div>
  
  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Adults:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">0.1 mg/kg/h (CrCl 30–60 mL/min)</div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">0.07 mg/kg/h (CrCl 10–29 mL/min)</div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">0.02 mg/kg/h (CrCl &lt;10 mL/min)</div>
  
  <div class="mxb-6 plr-1 ptb-0-2 subhead-content"><b>Pediatrics:</b></div>
  <div class="mxb-12 plr-1 ptb-0-7 bg-white border-tb">0.15 mg/kg/h if CrCl &lt;60 mL/min</div>  
</div>